Browse By: Country ι Category ι Publisher ι Tag

Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors

Pages » 301
Published By » La Merie Publishing
Price » $2092
In stock
View Report Details
Description

Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors The new Competitive Intelligence Report Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis in the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and biobetter/biosuperior versions in regulated and less regulated markets: Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) G-CSF & GM-CSF Thrombopoietin & Thrombopoiesis Stimulating Agents Interferon Insulin Coagulation Factors Human Growth Hormone (hGH) FSH, hCG and LH: Therapeutic Pro...


Oncology Pipeline Database: 6-Month Subscription
Oncology Pipeline Database: 6-Month Subscription Product description Subscription to La Merie’s proprietary Oncology Pipeline Database provides online access to more than 3,000 project entries in oncology. Each project is specified for its Target or Mechanism of Action, Product Category and
Published Date: Feb 2010
Price: $1544
Oncology Pipeline Database: 1-Year Subscription
Oncology Pipeline Database: 1-Year Subscription Product description Subscription to La Merie’s proprietary Oncology Pipeline Database provides online access to more than 3,000 project entries in oncology. Each project is specified for its Target or Mechanism of Action, Product Category and R
Published Date: May 2010
Price: $2316
Flat-Rate Subscription to La Merie Reports with 24/7 Online Access
Subscription to this product provides online access during one year to all reports published by La Merie and available in the online store during the subscription. Among La Merie reports are more than 100 Competitor Analysis reports as well as a growing number of Brief and Full Reports. La Merie r
Published Date: Jun 2010
Price: $5146
R&D Drug Pipeline Database: 1-Year Subscription
R&D Drug Pipeline Database: 1-Year Subscription Product description Subscription to La Meries proprietary R&D Drug Pipeline Database provides online access to more than 12,000 project entries in all therapeutic areas and product categories. Each project is specified for its Target or Mecha
Published Date: Aug 2010
Price: $7719
R&D Drug Pipeline Database: 2-Months Subscription
R&D Drug Pipeline Database: 2-Months Subscription Product description Subscription to La Meries proprietary R&D Drug Pipeline Database provides online access to more than 12,000 project entries in all therapeutic areas and product categories. Each project is specified for its Target or Mec
Published Date: Aug 2010
Price: $2573
Antibody Pipeline Database: 1-Year Subscription
Subscription to La Meries proprietary Antibody Pipeline Database provides online access to more than 1,600 project entries for therapeutic antibodies on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase.
Published Date: Nov 2010
Price: $1544
Therapeutic Protein Pipeline Database: 1-Year Subscription
Subscription to La Merie’s proprietary Therapeutic Protein Pipeline Database provides online access to more than 1,700 project entries for therapeutic proteins on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area a
Published Date: Feb 2011
Price: $1544
RNA Therapeutics Pipeline Database: 1-Year Subscription
RNA Therapeutics Pipeline Database: 1-Year Subscription Product description Subscription to La Merie’s proprietary RNA Therapeutics Pipeline Database provides online access to RNA Therapeutics on the market and in research & development. RNA Therapeutics include the classes of antisense,
Published Date: Mar 2011
Price: $772
Vaccine Pipeline Database: 1-Year Subscription
Vaccine Pipeline Database: 1-Year Subscription Product description Subscription to La Merie’s proprietary Vaccine Pipeline Database provides online access to more than 1,200 project entries for prophylactic and therapeutic vaccines on the market and in research & development. Eac
Published Date: Oct 2011
Price: $1287
Competitor Analysis: Targeted Therapy of Hepatitis C
The present Competitive Intelligence Report about Targeted Therapy of Hepatitis C provides a competitor evaluation in the field of specifically targeted antiviral therapeutics for hepatitis C (STAT-C) as of August 2011. Purchase of the downloadable pdf report includes a 6-month online access to
Published Date: Aug 2011
Price: $772

 


 

Related News

Egyptian Government to Allow Private Investments in Renewable and New Energy Sector
As Egypt grapples its worst electricity crisis, the country’s government has decided to allow the private sector’s participation in renewable energy initiatives. According to Mohamed Shaker, Egypt’s Minister of Electricity, the government has agreed private sector investments in the production of new and renewable energy in Egypt. However, this participation will be subject to a tariff policy for the government’s purchase of energy produced by the private sector, over the
Date: Aug 28

New App Released By Instagram for Time-lapse Videos
A new iPhone app called Hyperlapse was released by Instagram on Tuesday. This app erases out the disturbances and jitters caused in time-lapse videos. Interestingly, a similar technology was demonstrated by Microsoft a couple of weeks back and that too bearing the same name. According to analysts, this app is a striking feature introduced in the video aspect of smart phones. Passage of time can be depicted by using a widely used video technique called time lapse. However, these effects can be
Date: Aug 28

Adani to Purchase Royalty Rights of Australia Coal Mine from Linc
Adani Enterprises has agreed to buy the Australian mining firm’s rights to royalties to Linc Energy - an amount worth Australian dollar (A$) 155 million (USD 145 million). The royalties from Adani is high, however is already delayed four years behind schedule regarding Carmichael coal project. The deal raises questions as to whether Adani will build the project and become Australia’s biggest mining company, amid all the antagonisms from decline in coal prices and green groups. This
Date: Aug 28

Germany Trims Non-Renewable Energy Sector, Companies Worry about Growth
Many of Germany’s companies, investors, economists, and neighboring countries are worried about Germany’s move to introduce a large-scale renewable energy program. The country faces enormous costs to replace a system that was already in effect and working, with a project to start utilizing cleaner energy sources. In their effort to gradually wean off nuclear and fossil fuel energy, Germany’s Energiewende plans to spend a trillion Euros to do so. The North Sea wind farm Bard
Date: Aug 27

GM Faulty Ignition-switch Program Registers More than 100 Death Claims
The General Motors’ program built to compensate victims of crashes caused due to faulty ignition switches in company’s vehicles has received 107 claims for death as of Tuesday, according to Amy Weiss, the spokesperson for Kenneth Feinberg - the lawyer handling the program.  Amy stated that the 107 death claims are amongst the 309 claims submitted in the program so far. The program started to accept claims on the 1st August, and will continue till 31st December.  For a
Date: Aug 27

Japan Energy Sector Develops First 250MW Solar Power Project
First Solar Inc., (FSLR)is constructing its first 250 megawatts solar projects in Japan. FSLR is the largest U.S. solar panel maker in the country. Japan witnesses many government incentives that encourage substantial development of solar and cleaner energy sources.  Karl Brutsaert, the director of business development First Solar told that Japan is strategically planning into making investments in utility-scale projects, developing different projects, operating and managing over the lon
Date: Aug 27

BOC Aviation Places Order For Boeing Planes Worth a Record Amount
The leasing subsidiary of Bank of China, BOC Aviation has recently placed the biggest order of planes in its 20-year history. The order, which is reportedly worth $8.8 billion, comprises of two long-haul wide-body planes of the 777-300ER series, 30 Next Generation aircrafts of the 737-800 series, 50 Boeing planes of the 737 Max 8 series. The order comes only a week after the China-based leasing body SMBC Aviation had placed orders for 115 Airbus jet planes.  The huge financing of leasin
Date: Aug 26

Japan to Seek Over ¥5 Trillion Defense Budget
In what is a record-high budget request, the defense ministry of Japan plans to request more than 5 trillion yen in the fiscal year 2015 beginning next April. A formal announcement will be made next Friday and includes high priority costs that are in line with Prime Minister Shinzo Abe’s new strategies on defense and security.  The budget sought after is 3.5% higher than this fiscal year’s request and includes defense of the remote islands of Japan, creation of an amphibious
Date: Aug 25

India to Global Auto Hub by 2020
Global automobile manufacturers are eyeing India as a lucrative option to set up businesses. This shift in perception is due to country’s growing domestic market and its growth potential. The automakers will also focus on exports from India. Report published by Standard Chartered Bank states, for global operations Hyundai will source its engines from India; Ford will manufacture engines in India for its Asia-Pacific and Africa region; and Volkswagen will increase its sourcing from India
Date: Aug 25

New Transparent Material can Work as a Solar Power Generator
A team of scientists at Michigan State University declared this week the creation of a luminescent transparent solar concentrator which has the potential to turn windows and cell phone screens into solar-power generating equipment. This technology can revolutionize the way we use solar power. It cans enable entire skyscrapers one day to generate solar power without obstructing light or the view. This new material works by absorbing light from the invisible spectrum which is ultraviolet and ne
Date: Aug 25

Upcoming Reports

Biopharmaceutical Licensing Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts, 2012 - 2018
The biopharmaceutical industry is focusing on the growing complexity of licensing deals in order to secure marketing and commercialization rights within partnership deals. The major challenge faced by the biopharmaceutical licensing market is asymmetry between licensor and licensees. The biopharma
Published By: Transparency Market Research
Price: $4795
US Biopharmaceutical Market - Global Industry Size, Market Share, Smart Trends, Analysis And Forecast, 2012 - 2018
Biopharmaceuticals are medical drugs which are produced with the help of biotechnology. The US is the largest market for biopharmaceuticals and is the leader in terms of revenue, by a substantial margin. The biopharmaceutical market can be classified based on the class of the medical drug into r
Published By: Transparency Market Research
Price: $4795
Orthopedic Bone Material (Cement and Casting) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
Artificial joints have been anchored with bone cements for more than half a century. Bone cement plays the important role of an elastic zone by filling the space between the prosthesis and the bone. The necessity of bone cement is supported by the fact that the human hip is acted on by 10-12 tim
Published By: Transparency Market Research
Price: $4595
Single-Use Technologies For Biopharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Single use technologies involve single-use or disposable products. Such products are usually made of plastics or its derivatives such as polyamides, polycarbonates, polyethylene, polyvinyl chloride and various others. These products are becoming popular in the biopharmaceutical applications as the
Published By: Transparency Market Research
Price: $4795